{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:38:58Z","timestamp":1760042338334},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s11886-006-0077-z","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T16:47:17Z","timestamp":1180975637000},"page":"370-376","source":"Crossref","is-referenced-by-count":8,"title":["Atrial fibrillation: Choosing an antiarrhythmic drug"],"prefix":"10.1007","volume":"8","author":[{"given":"Todd","family":"Rudo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kowey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"77_CR1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","volume":"155","author":"W Feinberg","year":"1995","unstructured":"Feinberg W, Blackshear JL, Laupacis, et al.: Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 1995, 155:469- 473.","journal-title":"Arch Intern Med"},{"key":"77_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.physiol.62.1.51","volume":"62","author":"S Nattel","year":"2000","unstructured":"Nattel S, Li D, Yue L: Basic mechanisms of atrial fibrillation - very new insights into very old ideas. Annu Rev Physiol 2000, 62:51\u201377.","journal-title":"Annu Rev Physiol"},{"key":"77_CR3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","volume":"339","author":"M Haissaguerre","year":"1998","unstructured":"Haissaguerre M, Jais P, Shah DC, et al.: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998, 339:659\u2013666.","journal-title":"N Engl J Med"},{"key":"77_CR4","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","volume":"92","author":"MC Wijffels","year":"1995","unstructured":"Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA:Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995, 92:1954\u20131968.","journal-title":"Circulation"},{"key":"77_CR5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0735-1097(01)01587-X","volume":"38","author":"V Fuster","year":"2001","unstructured":"Fuster V, Ryden LE, Asinger RW, et al.: ACC\/AHA\/ESC Guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol 2001, 38:1231\u20131266.","journal-title":"J Am Coll Cardiol"},{"key":"77_CR6","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"A Go","year":"2001","unstructured":"Go A, Hylek EM, Philips KA, et al.: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial fibrillation study (ATRIA). JAMA 2001, 285:2370\u20132375.","journal-title":"JAMA"},{"key":"77_CR7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","volume":"306","author":"WB Kannel","year":"1982","unstructured":"Kannel WB, Abbott RD, Savage DD, McNamara PM:Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982, 306:1018\u20131022.","journal-title":"N Engl J Med"},{"key":"77_CR8","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","volume":"154","author":"Atrial Fibrillation Investigators","year":"1994","unstructured":"Atrial Fibrillation Investigators: Risk factors for stroke and Efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994, 154:1449\u20131457.","journal-title":"Arch Intern Med"},{"key":"77_CR9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","volume":"30","author":"RG Hart","year":"1999","unstructured":"Hart RG, Pearce LA, McBride R, et al.: Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. Stroke 1999, 30:1223\u20131229.","journal-title":"Stroke"},{"key":"77_CR10","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1046\/j.1540-8167.14.s9.17.x","volume":"14","author":"DG Wyse","year":"2003","unstructured":"Wyse DG: Rhythm versus rate control trials in atrial fibrillation. J Cardiovasc Electrophysiol 2003, 14:S35-S39. Consolidated review of the five major randomized controlled trials of rate control versus rhythm control strategies.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"77_CR11","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","volume":"347","author":"The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators","year":"2002","unstructured":"The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators: A comparison of rate control and rhythm control on patients with atrial fibrillation. N Engl J Med 2002, 347:1825\u20131833.","journal-title":"N Engl J Med"},{"key":"77_CR12","first-page":"903","volume":"76","author":"GW Dalzell","year":"1990","unstructured":"Dalzell GW, Anderson J, Adgey AA: Factors determining success and energy requirements for cardioversion of atrial fibrillation. Q J Med 1990, 76:903\u2013913.","journal-title":"Q J Med"},{"key":"77_CR13","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0735-1097(01)01540-6","volume":"38","author":"MM Gallagher","year":"2001","unstructured":"Gallagher MM, Guo XH, Poloniecki JD, et al.: Initial energy setting, outcome, and efficiency of direct current cardioversion of atrial fibrillation. J Am Coll Cardiol 2001, 38:1498\u20131504.","journal-title":"J Am Coll Cardiol"},{"key":"77_CR14","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJM199906173402401","volume":"340","author":"H Oral","year":"1999","unstructured":"Oral H, Souza JJ, Michaud GF, et al.: Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med 1999, 340:1849\u20131854.","journal-title":"N Engl J Med"},{"key":"77_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/euhj.1999.1734","volume":"21","author":"A Capucci","year":"2000","unstructured":"Capucci A, Villani GO, Aschieri D, et al.: Oral amiodarone increases the Efficacy of direct current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J 2000, 21:66\u201373.","journal-title":"Eur Heart J"},{"key":"77_CR16","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0735-1097(99)00256-9","volume":"34","author":"A DeSimone","year":"1999","unstructured":"DeSimone A, Stabile G, Vitale DF, et al.: Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol 1999, 34:810 -814.","journal-title":"J Am Coll Cardiol"},{"key":"77_CR17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/01.CIR.0000022665.18619.83","volume":"106","author":"AH Madrid","year":"2002","unstructured":"Madrid AH, Bueno MG, Rebollo JM, et al.: Use of irbesartan to maintain sinus rhythm in patients with long-standing persistent atrial fibrillation: a prospective and randomized study. Circulation 2002, 106:331\u2013336.","journal-title":"Circulation"},{"key":"77_CR18","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.2165\/00003495-200464240-00003","volume":"64","author":"G Boriani","year":"2004","unstructured":"Boriani G, Diemberger I, Bif. M, et al.: Pharmacologic cardioversion of atrial fibrillation: current management and treatment options. Drugs 2004, 64:2741\u20132762. A current, comprehensive review of the use of antiarrhythmic drugs in pharmacologic cardioversion.","journal-title":"Drugs"},{"key":"77_CR19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt DS, Liebson PR, Mitchell LB, et al.: Mortality and morbidity in patients receiving encainide, fiecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 1991, 324:781\u2013788.","journal-title":"N Engl J Med"},{"key":"77_CR20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00001573-199901000-00002","volume":"14","author":"A Capucci","year":"1999","unstructured":"Capucci A, Villani GO, Piepoli MF, Aschieri D: The role of oral IC antiarrhythmic drugs in terminating atrial fibrillation. Curr Opin Cardiol 1999, 14:4\u20138.","journal-title":"Curr Opin Cardiol"},{"key":"77_CR21","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1056\/NEJMoa041233","volume":"351","author":"P Alboni","year":"2004","unstructured":"Alboni P, Botto G, Baldi N, et al.: Outpatient treatment of recent onset atrial fibrillation with the \"pill-in-the-pocket\" approach. N Engl J Med 2004, 351:2384\u20132391.","journal-title":"N Engl J Med"},{"key":"77_CR22","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0735-1097(98)00078-3","volume":"31","author":"AS Volgman","year":"1998","unstructured":"Volgman AS, Carberry PA, Stambler BS, et al.: Conversion Efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998, 31:1414\u20131419.","journal-title":"J Am Coll Cardiol"},{"key":"77_CR23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0002-9149(86)90022-6","volume":"58","author":"A Borgeat","year":"1986","unstructured":"Borgeat A, Goy JJ, Maendly R, et al.: Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. Am J Cardiol 1986, 58:496\u2013498.","journal-title":"Am J Cardiol"},{"key":"77_CR24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0002-9149(98)00223-9","volume":"81","author":"J Reisinger","year":"1998","unstructured":"Reisinger J, Gatterer E, Heinze G, et al.: Prospective comparison of fiecainide versus sotalol for immediate cardioversion of atrial fibrillation. Am J Cardiol 1998, 81:1450\u20131454.","journal-title":"Am J Cardiol"},{"key":"77_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJM199407073310108","volume":"331","author":"SH Hohnloser","year":"1994","unstructured":"Hohnloser SH, Woosley RL: Sotalol. N Engl J Med 1994, 331:31\u201338.","journal-title":"N Engl J Med"},{"key":"77_CR26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0735-1097(96)00506-2","volume":"29","author":"RH Falk","year":"1997","unstructured":"Falk RH, Pollak A, Singh SN, Friedrich T, for the Intravenous Dofetilide Investigators: Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. J Am Coll Cardiol 1997, 29:385\u2013390.","journal-title":"J Am Coll Cardiol"},{"key":"77_CR27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0735-1097(02)02705-5","volume":"41","author":"P Chevalier","year":"2003","unstructured":"Chevalier P, Durand-Dubief A, Burri H, et al.: Amiodarone versus placebo and classic drugs for cardioversion of recent onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2003, 41:255\u2013262.","journal-title":"J Am Coll Cardiol"},{"key":"77_CR28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.CIR.97.5.493","volume":"97","author":"KT Murray","year":"1998","unstructured":"Murray KT: Ibutilide. Circulation 1998, 97:493\u2013497.","journal-title":"Circulation"},{"key":"77_CR29","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.94.7.1613","volume":"94","author":"BS Stambler","year":"1996","unstructured":"Stambler BS, Wood MA, Ellenbogen KA, et al.: Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996, 94:1613\u20131621.","journal-title":"Circulation"},{"key":"77_CR30","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/hrt.79.6.568","volume":"79","author":"MA Vos","year":"1998","unstructured":"Vos MA, Golitsyn SR, Stangl K, et al.: Superiority of ibutilide over sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide\/Sotalol Comparator Study Group. Heart 1998, 79:568\u2013575.","journal-title":"Heart"},{"key":"77_CR31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cpcardiol.2004.09.002","volume":"30","author":"A Hersi","year":"2005","unstructured":"Hersi A, Wyse DG: Management of atrial fibrillation. Curr Probl Cardiol 2005, 30:175\u2013234. Very current and thorough review of AF management, including both pharmacologic and nonpharmacologic therapies.","journal-title":"Curr Probl Cardiol"},{"key":"77_CR32","first-page":"181","volume-title":"Atrial Fibrillation","author":"JR Ehrlich","year":"2005","unstructured":"Ehrlich JR and Hohnloser S: Pharmacologic cardioversion of atrial fibrillation. In Atrial Fibrillation. Edited by Kowey P, Naccarelli G. New York: Marcel Dekker; 2005:181\u2013194. This text is a current and comprehensive review of all aspects of AF, including epidemiology, pathophysiology, management strategies, antiarrhythmic drugs, and nonpharmacologic therapies."},{"key":"77_CR33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","volume":"342","author":"D Roy","year":"2000","unstructured":"Roy D, Talajic M, Dorian P, et al.: Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000, 342:913\u2013920.","journal-title":"N Engl J Med"},{"key":"77_CR34","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","volume":"352","author":"BN Singh","year":"2005","unstructured":"Singh BN, Singh SN, Reda DJ, et al.: Amiodarone versus sotalol for atrial fibrillation. New Engl J Med 2005, 352:1861\u20131872.","journal-title":"New Engl J Med"},{"key":"77_CR35","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","volume":"102","author":"S Singh","year":"2000","unstructured":"Singh S, Zoble RG, Yellen L, et al.: Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 2000, 102:2385\u20132390.","journal-title":"Circulation"},{"key":"77_CR36","first-page":"1633","volume":"98","author":"RA Greenbaum","year":"1998","unstructured":"Greenbaum RA, Campbell TJ, Channer KS, et al.: Conversion of atrial fibrillation and maintenance of sinus rhythm by dofetilide. The EMERALD (European and Australian Multicenter Evaluative Research on Atrial Fibrillation Dofetilide) Study [abstract]. Circulation 1998, 98:1633.","journal-title":"Circulation"},{"key":"77_CR37","doi-asserted-by":"crossref","first-page":"60A","DOI":"10.1016\/S0002-9149(97)89119-9","volume":"77","author":"M Chimienti","year":"1996","unstructured":"Chimienti M, Cullen MT, Casadei, G: Safety of long-term fiecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the fiecainide and propafenone Italian Study Investigators. Am J Cardiol 1996, 77:60A-65A.","journal-title":"Am J Cardiol"},{"key":"77_CR38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt DS, Liebson PR, Mitchell LB, et al.: Mortality and morbidity in patients receiving encainide, fiecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991, 324:781\u2013788.","journal-title":"N Engl J Med"},{"key":"77_CR39","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0002-9149(03)00974-3","volume":"92","author":"EL Prichett","year":"2003","unstructured":"Prichett EL, Page RL, Carlson M, et al.: Rythmol Atrial Fibrillation Trial (RAFT) Investigators: Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation. Am J Cardiol 2003, 92:941\u2013946.","journal-title":"Am J Cardiol"},{"key":"77_CR40","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0002-9149(02)02867-9","volume":"90","author":"T Meinertz","year":"2002","unstructured":"Meinertz T, Gregory YH, Fedrico L, et al.: Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol\/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study). Am J Cardiol 2002, 90:1300\u20131306.","journal-title":"Am J Cardiol"},{"key":"77_CR41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0002-9149(99)00275-1","volume":"84","author":"DG Benditt","year":"1999","unstructured":"Benditt DG, Williams JH, Jin J, et al.: Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and\/or atrial flutter. d,l-Sotalol Atrial Fibrillation\/Flutter Study Group. Am J Cardiol 1999, 84:270\u2013277.","journal-title":"Am J Cardiol"},{"key":"77_CR42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-8703(97)70186-8","volume":"133","author":"RS Wanless","year":"1997","unstructured":"Wanless RS, Anderson K, Joy M, Joseph SP: Multicenter comparative study of the Efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias. Am Heart J 1997, 133:441\u2013446.","journal-title":"Am Heart J"},{"key":"77_CR43","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","volume":"104","author":"V Fuster","year":"2001","unstructured":"Fuster V, Ryden LE, Asinger RW, et al.: ACC\/AHA\/ESC Guidelines for the management of patients with atrial fibrillation: executive summary. Circulation 2001, 104:2118\u20132150.","journal-title":"Circulation"},{"key":"77_CR44","first-page":"195","volume-title":"Atrial Fibrillation.","author":"JA Reiffel","year":"2005","unstructured":"Reiffel JA: Maintenance of normal sinus rhythm with antiarrhythmic drugs. In Atrial Fibrillation. Edited by Kowey P, Naccarelli G. New York: Marcel Dekker; 2005:195\u2013217."},{"key":"77_CR45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00001573-200001000-00002","volume":"15","author":"JA Reiffel","year":"2000","unstructured":"Reiffel JA: Inpatient versus outpatient antiarrhythmic drug initiation: safety and cost-effectiveness issues. Curr Opin Cardiol 2000, 15:7\u201311.","journal-title":"Curr Opin Cardiol"},{"key":"77_CR46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0735-1097(98)00186-7","volume":"32","author":"FI Marcus","year":"1998","unstructured":"Marcus FI: Risks of initiating therapy with sotalol for treatment of atrial fibrillation. J Am Coll Cardiol 1998, 32:177\u2013180.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-006-0077-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-006-0077-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-006-0077-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:56:06Z","timestamp":1559433366000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-006-0077-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["77"],"URL":"https:\/\/doi.org\/10.1007\/s11886-006-0077-z","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}